Five hundred forty-eight uncoagulated blood specimens from intravenous drug users infected with human T-lymphotropic virus type II (HTLV-II) were used to evaluate the sensitivities of the radioimmunoprecipitation assay (RIPA) and PCR for detecting HTLV-II-infected people. The sensitivities of both RIPA and PCR were found to be dependent on the HTLV-II antibody titer, as determined by the immunofluorescence assay. Neither of these recommended confirmatory methods was as sensitive for detecting weakly reactive HTLV-II specimens as the immunofluorescence assay, Western blotting (immunoblotting), or a modified licensed enzyme immunoassay. Use of RIPA and PCR to determine the reliabilities of other tests may sometimes give erroneous results.
recombinant gp2l from Hoffmann-La Roche Inc., Nutley, N.J. (3) , or commercial WB strips (Cambridge Biotech Corp., Worcester, Mass.) containing HTLV-I viral lysate and recombinant gp2l. A specimen was considered positive if it reacted with envelope proteins and either p19 or p24.
RIPA. The specimens were reacted with HTLV-I (MT2) and HTLV-II (clone 19) RIPA antigen containing 35S-labeled methionine and 35S-labeled cysteine. Clone 19 is an HTLV-IItransformed cell line established in this laboratory from an intravenous drug user from California infected with HTLV-II (5) . The test was performed as described previously (3) . A specimen was considered positive if it reacted with either the gp68 band with the HTLV-I antigen or the gp67 band with the HTLV-II antigen.
PCR. PCR was performed on all HTLV antibody-positive samples. Peripheral blood mononuclear cells were isolated from approximately 14 ml of uncoagulated blood by centrifugation through Ficoll-Hypaque. One dry cell pellet and two vials of cells containing 10% fetal bovine serum and 10% dimethyl sulfoxide were stored at -70°C. PCR was performed on the thawed pellet as described previously (8) probe. This nested primer procedure has been shown to increase the sensitivity of HTLV PCR with some samples (6) . If neither HLA nor HTLV DNA was detected, further efforts included purification of the sample with chloroform (9) or Chelex 100 (7), dilution of the purified product, and repetition of PCR with new lysate.
RESULTS
Seventy (12.8%) of the 548 positive samples were negative by the Abbott EIA but were detected by IFA and were confirmed by WB and RIPA or PCR. Although some of these EIA-negative specimens had relatively high IFA titers with the HTLV-II antigen, they all displayed HTLV-I titers of 1:64 or less. In our experience, the sensitivity of this EIA is dependent on the anti-HTLV-I titer of the specimen. We have not experienced a false-negative EIA reaction in a specimen with an HTLV-I IFA titer of :1:128.
In Table 1 working to improve the reliability of their EIA kits. However, only 28 of the 50 weakly reactive specimens in Table 2 reacted with the env band of the HTLV-I antigen in RIPA and were also PCR positive in the first run. Presumably, many of these samples would be deemed negative for HTLV antibody in other laboratories. Developmental tests for the detection of HTLV antibody may suffer from undeserved low specificities because they are more sensitive than the RIPA and the PCR used to determine these values. 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48 64  16  16  32  32  16  4  32  16  16  16  64  64  64  64  16  16  8  32  32  16  32  4  8  4  4  16  64  32  16  16  16  32  16  16  16  16  16  16  16  8  16  16  16  64  16  4  4  8 
